7TM pharmacology measured by label-free: a holistic approach to cell signalling

Current Opinion in Pharmacology

Volumn 9, Issue 5, 2009, Pages 643-649

  Rocheville, Magalie ^a   Jerman, Jeff C ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 1H 3 BENZAZEPINE; BETA 2 ADRENERGIC RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; HISTAMINE H1 RECEPTOR; MEMBRANE RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2;

CELL ACTIVITY; CELL ADHESION; CELL ASSAY; CELL DEATH; CELL LABELING; CELL MIGRATION; CELL PROLIFERATION; DRUG EFFICACY; DRUG RESEARCH; DRUG SCREENING; HUMAN; METHODOLOGY; MOLECULAR BIOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BINDING SITES; BIOLOGICAL ASSAY; DRUG DESIGN; HUMANS; LIGANDS; MOLECULAR STRUCTURE; PROTEIN CONFORMATION; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 70349416545     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2009.06.015     Document Type: Review

References (36)

1. Kenakin T. Drug efficacy at G protein-coupled receptors. Annu Rev Pharmacol Toxicol 42 (2002) 349-379
2. Kenakin T. New concepts in drug discovery: Collateral efficacy and permissive antagonism. Nat Rev Drug Discov 4 (2005) 919-927
3. Nelson C.P., and Challiss R.A. Phenotypic pharmacology: The influence of cellular environment on G protein-coupled receptor antagonist and inverse agonist pharmacology. Biochem Pharmacol 73 (2006) 737-751
4. Eglen R.M. Emerging concepts in GPCR function-the influence of cell phenotype on GPCR pharmacology. Proc West Pharmacol Soc 48 (2005) 31-34
5. Kenakin T. Collateral efficacy in drug discovery: Taking advantage of the good (allosteric) nature of 7TM receptors. Trends Pharmacol Sci 28 (2007) 407-415. The author reviews the collateral nature of ligand efficacy in which ligands can produce portions of the possible receptor behaviours. Part of a special edition of TiPS focused on allosterism and functional selectivity.
6. Galadrin S., Oligny-Longpre G., and Bouvier M. The evasive nature of drug efficacy: Implications for drug discovery. Trends Pharmacol Sci 28 (2007) 423-430. The authors cover the challenges of measuring ligand efficacy and the impact pluridimensional efficacy may bear towards drug discovery. Part of a special edition of TiPS focused on allosterism and functional selectivity.
7. Baker J.G., and Hill S.G. Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates. Trends Pharmacol Sci 28 (2007) 374-381
8. Violin J.D., and Lefkowitz R.J. β-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol Sci 28 (2007) 416-422
9. Gilchrist A. Modulating G-protein-coupled receptors: from traditional pharmacology to allosterics. Trends Pharmacol Sci 28 (2007) 431-437
10. Urban J.D., Clarke W.P., von Zastrow M., Nichols D.E., Kobilka B., Weinstein H., Javitch J.A., Roth B.L., Christopoulos A., Sexton P.M., et al. Functional selectivity and classical concepts of quantitative pharmacology. J Phamacol Exp Ther 320 (2007) 1-13
11. Eglen R., Bosse R., and Reisine T. Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screening. Assay Drug Dev Technol 5 (2007) 425-451
12. Thomsen W., Frazer J., and Unett D. Functional assays for screening GPCR targets. Cur Opin Biotechnol 16 (2005) 655-665
13. Siehler S. Cell-based assays in GPCR drug discovery. Biotechnol J 3 (2008) 471-483
14. Cooper M.A. Optical biosensors: what next and how soon?. Drug Discov Today 11 (2006) 1061-1067
15. Cooper M.A. Non-optical screening platforms: the next wave in label-free screening?. Drug Discov Today 11 (2006) 1068-1074
16. Minor L. Label-free cell-based functional assays. Comb Chem High Thr Screen 11 (2008) 573-580. Comprehensive review of label-free detection applied to cellular screening, covering examples of receptor tyrosine kinases and 7TMs.
17. Ciabrone G.J., Liu V.F., Lin D.C., McGuinness R.P., Leung G.K., and Pitchford S. Cellular dielectric spectroscopy: a powerful new approach to label-free cellular activity. J Biomol Screen 9 (2004) 467-480
18. Atienza J.M., Yu N., Kirstein S.L., Xi B., Wang X., Xu X., and Abassi Y.A. Dynamic and label-free cell-based assays using the real-time cell electronic sensing system. Assay Drug Dev Technol 4 (2006) 597-607
19. Fang Y. Label-free cell-based assays with optical biosensors in drug discovery. Assay Drug Dev Technol 4 (2006) 583-596
20. McGuinness R. Impedance-based cellular assay technologies: recent advances, future promise. Curr Opin Pharmacol 7 (2007) 535-540
21. Xi B., Yu N., Wang X., Xu X., and Abassi Y.A. The application of cell-based label-free technology in drug discovery. Biotechnol J 3 (2008) 484-495
22. Fang Y., Frutos A.G., and Verklereen R. Label-free cell-based assays for GPCR screening. Comb Chem High Thr Screen 11 (2008) 357-369. The authors provide an extensive overview of the latest advances in label-free with respect to 7TM cellular signalling.
23. Verdonk E., Johnson K., McGuiness R., Leung G., Chen Y.-W., Tang H.R., Michelotti J.M., and Liu V.F. Cellular dielectric spectroscopy: a label-free comprehensive platform for functional evaluation of endogenous receptors. Assay Drug Dev Technol 4 (2006) 609-619. The authors investigate the applicability of impedance-based label-free detection towards identification and mechanistic characterisation of endogenous 7TMs.
24. Fang Y., and Ferrie A.M. Label-free optical biosensor for ligand-directed functional selectivity acting on beta(2) adrenoceptor in living cells. FEBS Lett 582 (2008) 558-564. The study examines the potential of label-free to elucidate functional selectivity of various ligands by profiling A431 cells endogenously expressing β2ARs.
25. Lee P.H., Gao A., Van Staden C., Ly J., Salon J., Xu A., Fang Y., and Verkleeren R. Evaluation of dynamic mass redistribution technology for pharmacological studies of recombinant and endogenously expressed G protein-coupled receptors. Assay Drug Dev Technol 6 (2008) 83-94
26. Fang Y., Li G., and Ferrie A. Non-invasive optical biosensor for assaying endogenous G protein-coupled receptors in adherent cells. J Pharmacol Toxicol Meth 55 (2007) 314-322
27. Yu N., Atienza J.M., Bernard J., Blanc S., Zhu J., Wang X., Xu X., and Abassi Y.A. Real-time monitoring of morphological changes in living cells by electronic cell sensor arrays: an approach to study G protein-coupled receptors. Anal Chem 78 (2006) 35-43
28. Fang Y., Li G., and Peng J. Optical biosensor provides insights for bradykinin B2 receptor signaling in A431 cells. FEBS Lett 579 (2006) 6365-6374
29. Fang Y., and Ferrie A.M. Optical biosensor differentiates signaling of endogenous PAR1 and PAR2 in A431 cells. BMC Cell Biol 8 (2007) 24-36
30. Tran E., and Fang Y. Duplexing label-free G protein coupled receptor assays for high throughput screening. J Biomol Screen 13 (2008) 975-985
31. Fang Y., Ferrie A.M., Fontaine N.H., Mauro J., and Balakrishnan J. Resonant waveguide grating biosensor for living cell sensing. Biophys J 91 (2006) 1925-1940
32. Peters M.F., and Scott C.W. Evaluating cellular impedance assays for detection of GPCR pleiotropic signalling and functional selectivity. J Biomol Screen 14 (2009) 246-255. The authors evaluated several 7TMs for cell-specific signalling, dual signalling and functional selectivity using impedance-based label-free detection.
33. Ryman-Rasmussen J.P., Nichols D.E., and Mailman R.B. Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists. Mol Pharmacol 68 (2005) 1039-1048
34. Liu J., Wang F., Huang C., Long L.H., Wu W.N., Cai F., Wang J.H., Ma L.Q., and Chen J.G. Activation of phosphatidylinositol-linked novel D1 dopamine receptor contributes to the calcium mobilization in cultured rat prefrontal cortical astrocytes. Cell Mol Neurobiol 29 (2009) 317-328
35. 2+ currents in primary cultured striatal neurons. J Neurophysiol 101 (2009) 2230-2238
36. Mannoury la Cour C., Vidal S., Pasteau V., Cussac D., and Millan M.J. Dopamine D1 receptor coupling to Gs/olf and Gq in rat striatum and cortex: a scintillation proximity assay (SPA)/antibody-capture characterization of benzazepine agonists. Neuropharmacol 52 (2007) 1003-1014